Posters 2 — ASN Events

Posters 2 — ASN Events

Posters 2

Development of a standardised oral anticancer therapy reference manual in a specialist cancer centre pharmacy department (#291)

Peninsula Health Workforce Development (#292)

Paula N Balchin

To utilise a change management process to the implementation of the Antineoplastic Drug Administration Course (ADAC) into four health services within the Southern Melbourne region (#293)

Australian cancer consumer advocacy movement: at twenty-one, 1994-2015 (#294)

Sally Crossing AM

The cancer cup challenge – running an international program in safety and quality in oncology (#295)

Are self-administered psychosocial interventions as efficacious as guided interventions in the management of chronic health conditions? (#296)

Janelle Levesque

Communication skills training for oncology health care professionals working with culturally and linguistically diverse patients (#297)

Non-HIV-associated Kaposi sarcoma in an immunosuppressed melanoma patient (#298)

Patient Understanding of Research in a Medical Oncology Settting (#299)

Natasha Roberts

Development of Standardised Manufacturing Guidelines for Anticancer Therapies (#300)

How should we provide education to our patients? (#301)

Does the role of evidence, change nursing practice when handling antineoplastic medications and related waste? (#302)

Michelle Weston

Retrospective Audit of patients with Early Breast Cancer Treated at Princess Alexandra Hospital from 2012-2014 to identify median time from diagnosis of early breast cancer to surgery, median time from surgery to initiation of chemotherapy and rates of re-excision. (#303)

Establishment of a multidisciplinary team approach to complex pain management in Rural Victoria (#304)

Bertilla Campbell

A cost-benefit evaluation of prophylactic biosimilar filgrastim for breast cancer patients receiving adjuvant TC chemotherapy. (#305)

A snapshot review of the impact of a Rapid Assessment Clinic on the care pattern of febrile neutropenic patients (#306)

Madhawa De SIlva

Coordinating care for people with colorectal cancer: a population-based survey of patient experiences in NSW (#307)

Audit of compliance with a limitation of medical treatment instrument entitled ‘Goals of Care Plan’ (GOCP) prior to inpatient death at the Royal Hobart Hospital (RHH). (#308)

Christine Edwards

The challenge of treating Lentigo Maligna (LM); An international multicentre randomised trial comparing radiation therapy to imiquimod for patients diagnosed with complex LM (#309)

Acceptability and utility of a telephone outcall program for carers of persons diagnosed with cancer (#311)

Recruitment of carer/person with cancer dyads into a randomised controlled trial: factors associated with non-participation and reasons for decline (#312)

Funding a regional cancer clinical trials centre through community engagement (#313)

A state-wide approach to survivorship care in South Australia (#314)

Chantelle Hislop

Perth Metropolitan Hospital Chemotherapy Day Unit Waiting Times and Patient Satisfaction (#315)

An audit of pregnancy screening prior to chemotherapy administration (#316)

Evaluating the effectiveness of the Prostate Cancer Clinical Nurse Co-ordinator (PC-CNC) role in Australia (#317)

Ilona Juraskova

Prostate Cancer Clinical Nurse Coordinator (PC-CNC) Role: Qualitative Exploration of the Coordinator Intervention Impact (#318)

Ilona Juraskova

Discussing and prescribing expensive unfunded anticancer drugs in Australia (#319)

Deme J Karikios

An analysis of under-infusing fluorouracil elastomeric infusion devices (#320)

Review of an innovative health service approach, the Symptom Urgent Review Clinic (SURC), to improve efficiency and quality of care for breast cancer patients receiving adjuvant chemotherapy (#321)

‘Nutrition’ related calls to a Cancer Helpline: What are they really about? (#322)

Patient Factors that Influence Outpatient Chemotherapy Delivery Scheduling Preferences (#323)

“The incidental support group”: The treatment team playing a central role in the sphere of care (#324)

Breast Cancer Management and Outcomes in Regional Victoria (#325)

Lisi Elizabeth Lim

M-Health: the impact of smartphone technology to improve quality of life outcomes among people with cancer: a randomised controlled trial (#326)

Patricia Livingston

Clinical trial protocol - Implementing clinical practice guidelines for cancer pain in adults to ensure equitable, cost-effective, evidence-based, person-centred care:A phase III pragmatic stepped wedge cluster randomised controlled trial of guidelines and screening with implementation strategies versus guidelines and screening alone to improve pain in adults with cancer attending outpatients oncology and palliative care centres (#327)

Delegate? Skill Share? Or Uni-professional? A Framework to address to address allied health(AH) workforce shortages. (#328)

Juanine Passfield

How deep are the potholes? Quantifying and describing allied health(AH) road blocks to transitioning to local care. (#329)

Juanine Passfield

The Lung Cancer Demonstration Project: Implementation and evaluation of a lung cancer multidisciplinary team (MDT) communication tool for general practitioners (GPs) (#330)

Member experiences in an Australian Translational Cancer Research Centre, Sydney Catalyst, and their understanding of translational research (#331)

Clinicians views to inform the next Victorian Government Cancer Plan (#332)

Screening for Circulating Tumour Cells allows early detection of cancer (#333)

Evaluating a direct access colonoscopy program for suspected colorectal cancer. (#334)

Medicinal cannabis in Victoria: potential law reform and Victorian cancer clinicians’ attitudes and experiences (#336)

Canrefer: Enhancement of the Online Cancer Services Directory for NSW (#337)

The clincal trial pharmacist’s role in reviewing medication related enquiries for patients enrolled in an oncology clinical trial (#338)

Samantha Wieringa

Mapping lung cancer diagnostic pathways: a qualitative study of interviews with lung cancer patients and their caregivers (#339)

Survivorship care for people with colorectal cancer: a population-based survey of patients' experiences and preferences (#340)

A qualitative research to understand public perception of personalised cancer medicine (PCM) and its application in treatment of advanced lung cancer (#341)

Real world experience from crizotinib in patients with ALK positive advanced NSCLC, from a compassionate use program run in Australia and New Zealand (#342)

Multidisciplinary Thyroid Cancer Clinic (#343)

Thyroid Cancer. Not Always Mr Nice Guy. (#344)

How accurately do research participants report a diagnosis of cancer? (#345)

Juliet Anderson

Second-line chemotherapy in advanced biliary tract cancer: A retrospective series (#346)

Outcomes and pattern of recurrence in patients with Stage III ALK-rearranged Non-Small Cell Lung Cancer treated with curative intent chemo-radiotherapy. (#347)

Symptom burden of Australia and New Zealand (ANZ) patients with Neuroendocrine Tumours (NET) (#348)

A retrospective study of dual ¹⁸F-fluorodeoxyglucose/⁶⁸Gallium DOTATATE (FDG/⁶⁸Ga-DOTATATE) positron emission tomography (PET) grading and its prognostic value in metastatic pancreatic neuroendocrine tumours (PNET) (#349)

Experience of Australia and New Zealand (ANZ) patients with neuroendocrine tumours (NET) treated at a NET specialist centre: Results of a national survey and the Royal North Shore experience (#350)

Adolescents and Young Adults living with cancer: Patterns of Care and Referral in South Western Sydney Local Health District (SWSLHD) (#351)

Implementation of telemedicine as a method for case conferencing in paediatric radiation oncology (#352)

Anal Cancer - A single centre experience (#353)

An audit of patients with mature T cell non-Hodgkin’s lymphoma by transplant status in Tasmania (#354)

Ciara J Conduit

Retrospective review of stereotactic radiotherapy for Chordoma and Chondrosarcoma of the skull base and spine (#356)

Association of CCR5Δ32 Mutation in Breast Cancer Patients of Pakistan. (#357)

Clinical profile and treatment outcomes of advanced neuroendocrine tumours in rural and remote patients: a retrospective study from a regional cancer centre in North Queensland, Australia. (#358)

Treatment and survival outcomes for neoadjuvant chemotherapy in muscle invasive bladder cancer: a retrospective study from several cancer centres in Australia. (#359)

Neuroendocrine Transformation of a Presacral Teratoma in Two Patients with Currarino Syndrome (#360)

Extraordinary response of an aggressive KIT-negative intra-abdominal fibromatosis to therapy with Imatinib mesylate: a Case-report (#361)

Efficacy and safety of lenvatinib for the treatment of patients with ¹³¹I-refractory differentiated thyroid cancer with and without prior VEGF-targeted therapy (#362)

Effect of age and lenvatinib treatment on overall survival for patients with ¹³¹I-refractory differentiated thyroid cancer in SELECT (#363)

Pharmacodynamic biomarkers of outcomes in the phase III study of lenvatinib in ¹³¹I-refractory differentiated thyroid cancer (SELECT). (#364)

Management and outcomes of metastatic leiomyosarcoma in pregnancy (#365)

Paraganglioma in a Pregnant Woman – A Case Report (#366)

ALK Translocated Non-Small Cell Lung Cancer: Experience from an Australian metropolitan tertiary referral centre. (#367)

Malinda Itchins

Management of Hypertensive Crisis in Paraganglioma-A Case Report (#368)

Correlation of Body Mass Index (BMI) with recurrence pattern and survival outcomes in endometrial cancer patients receiving adjuvant radiotherapy with or without chemotherapy: a retrospective study (#369)

Yada Kanjanapan

A Retrospective casenotes audit of clinico-pathologic characteristics of Neuroendocrine Tumours in Northern Territory (NET-NT) (#370)

Narayan Karanth

Neuroendocrine carcinoma of the cervix: An exploratory study of the prevalence of emotional and psychological distress levels and needs for support from the patient experience (#371)

A single centre audit on the pattern of care of patients with well differentiated neuroendocrine tumours compared to current guidelines (#372)

The experiences of mothers with multiple myeloma living in rural and regional Australia (#373)

Janelle V Levesque

NET Care in Australia; The patient’s perspective of their Neuroendocrine Tumours (NET) and impact of diagnosis (#374)

Case report of two cases of adenoid cystic carcinoma (#375)

Nicholas Linklater

Testicular cancer at the Top End: Retrospective review of case notes from 2000 -2014 (#376)

A survey of the current provision of screening tumours for mismatch repair deficiency in Australia: An Inherited Cancer Connect Partnership (ICCon) initiative (#377)

Lyon Mascarenhas

The psychosocial effects of a whole body MRI screening trial in sarcoma patients with a germline TP53 mutation (#378)

Developing a Management Algorithm for a Rare Cancer: Desmoid Tumours (#379)

Kortnye M Morris

Metastatic thyroid cancer: three extraordinary cases highlighting management principles and recent advances (#380)

Krithika Murali

Merkel cell carcinoma: lymphatic mapping for target definition in elective radiation therapy of regional nodes (#382)

Utilization of fluorescence in situ hybridization (FISH) in the diagnosis of rare bone and soft tissue neoplasms: experience at the Royal Prince Alfred Hospital, Sydney, Australia. (#383)

Does the prevalence of anxiety and depression for diffuse large B-cell lymphoma cancer survivors change over time: a prospective study (#384)

Devesh V Oberoi

Patterns of care and outcomes among sarcomatoid renal cell carcinoma patients in South Western Sydney (#385)

Shamsudheen Padinharakam

Salivary Duct Carcinoma: Clinicopathologic Features, Morphologic Spectrum and Somatic Mutations (#386)

Sandra A O’Toole

Radiotherapy or Chemo Radiotherapy in the treatment of Merkel cell carcinoma. An Update from the Chris O'Brien Lifehouse (#387)

Nazmeen Shameem

Evaluating the utility of the QUAL-EC in the clinical care of patients with advanced cancer (#388)

Anne M. Wilkinson

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer (#389)